Towards Healthcare

Cell Therapy Raw Materials Companies, Corporate Milestones, Corporate Growth and Development Strategy, Mergers and Acquisitions (M&A), Intellectual Property (IP) Portfolio Management, Market Trends Analysis, Leadership Alignment with Trends

Date : 07 January 2025

Cell Therapy Raw Materials Top Companies and Strategic Involvements

The global cell therapy raw materials market is valued at US$ 5.43 billion in 2024, increasing to US$ 6.75 billion in 2025, and is expected to reach approximately US$ 48.54 billion by 2034. This growth reflects a compound annual growth rate (CAGR) of 24.5% from 2025 to 2034.

Cell Therapy Raw Materials Market Companies

Top Companies in the Cell Therapy Raw Materials

  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • Danaher
  • Sartorius Stedim Biotech
  • Actylis.
  • ACROBiosystems
  • STEMCELL Technologies.
  • Grifols, S.A.
  • Charles River Laboratories
  • RoosterBio, Inc.
  • PromoCell GmbH

Shipping and Consignee Information in U.S. for Cell Therapy Raw Materials (2023 - 24)

CONSIGNEE_NAME SHIPPER_NAME HS_CODE SUMOFQUANTITY
E AND J GALLO TOYO SEIKAN CO LIMITED 847950 4151936
FRESENIUS KABI LLC HP HALDEN PHARMA AS SVINESUNDSVEIEN 300190 1231080
EUCATEX OF NORTH AMERICA INC EUCATEX INDUSTRIA E COMERCIO LTDA 382200 901730
LIFESCAN GLOBAL CORP LIFESCAN SCOTLAND LIMITED 382219 509454
DENSO MANUFACTURING CANADA INC DENSO SALES THAILAND CO LIMITED 847960 503636
TECHVAST CORP VESYNC SINGAPORE PRIVATE LIMITED 847960 428023